Evidence map›Paper›PMID 37085733›Full record

ArticleFunctional & integrative genomics2023

Transcriptomic analysis of lung development in wildtype and CFTR

Jenny L Kerschner, Alekh Paranjapye, Makayla Schacht, Frederick Meckler, Felix Huang, Gurkan Bebek, Arnaud J Van Wettere, Misha Regouski, Iuri Viotti Perisse, Kenneth L White and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Functional & integrative genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Cellular imbalance in proximal and distal lung of CFTRMolecular medicine (Cambridge, Mass.) · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Jenny L Kerschner *Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Alekh Paranjapye *Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Makayla SchachtDepartment of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Frederick MecklerDepartment of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Felix HuangDepartment of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Gurkan BebekCenter for Proteomics and Bioinformatics, Cleveland, OH, USA.
Arnaud J Van WettereDepartment of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UH, USA.
Misha RegouskiDepartment of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UH, USA.
Iuri Viotti PerisseDepartment of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UH, USA.
Kenneth L WhiteDepartment of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UH, USA.
Irina A PolejaevaDepartment of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UH, USA.
Shih-Hsing LeirDepartment of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Ann HarrisDepartment of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA. ann.harris@case.edu.
Utah State University · USUniversity School · USCase Western Reserve University · USUniversity of Pennsylvania · US

Funding

Cystic Fibrosis Foundation Harris21G0Cystic Fibrosis Foundation Leir21G0Cystic Fibrosis Foundation Polejaeva18G0
6 · The paper itself

Abstract

The precise molecular events initiating human lung disease are often poorly characterized. Investigating prenatal events that may underlie lung disease in later life is challenging in man, but insights from the well-characterized sheep model of lung development are valuable. Here, we determine the transcriptomic signature of lung development in wild-type sheep (WT) and use a sheep model of cystic fibrosis (CF) to characterize disease associated changes in gene expression through the pseudoglandular, canalicular, saccular, and alveolar stages of lung growth and differentiation. Using gene ontology process enrichment analysis of differentially expressed genes at each developmental time point, we define changes in biological processes (BP) in proximal and distal lung from WT or CF animals. We also compare divergent BP in WT and CF animals at each time point. Next, we establish the developmental profile of key genes encoding components of ion transport and innate immunity that are pivotal in CF lung disease and validate transcriptomic data by RT-qPCR. Consistent with the known pro-inflammatory phenotype of the CF lung after birth, we observe upregulation of inflammatory response processes in the CF sheep distal lung during the saccular stage of prenatal development. These data suggest early commencement of therapeutic regimens may be beneficial.

Indexed as

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorLungAnimalsGene Expression ProfilingInflammationSheepTranscriptomeCystic Fibrosis Transmembrane Conductance RegulatorCF sheepCystic fibrosisInflammatory responseLung developmentTranscriptomics

Identifiers

PMID37085733
PMCPMC10121546
OpenAlexW4366742795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.